[Use of levosimendan in children]

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Critical Care Medicine

Background:

• Levosimendan is a calcium-sensitizing drug with positive inotropic and vasodilatory effects.
• Its efficacy is established in adult cardiac surgery but pediatric use is limited.
• Growing evidence supports its use in pediatric acute and chronic heart failure.

Purpose of the Study:

• To review the pharmacodynamic effects of levosimendan in children.
• To describe current applications of levosimendan in pediatric heart failure.
• To explore future perspectives for levosimendan use in pediatric populations.

Main Methods:

• Literature review of studies on levosimendan in pediatric patients.
• Analysis of pharmacodynamic properties and clinical outcomes.
• Synthesis of current and potential applications.

Main Results:

• Levosimendan demonstrates favorable safety and efficacy profiles in neonates, infants, and children.
• It is increasingly utilized globally for various pediatric heart failure scenarios.
• Pharmacodynamic effects include inotropy and vasodilation, beneficial in pediatric cardiac dysfunction.

Conclusions:

• Levosimendan is a viable therapeutic option for pediatric heart failure.
• Further research and broader clinical adoption are warranted.
• Its role in managing pediatric cardiac conditions is expanding.